Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-03-30
1994-07-26
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 514 20, 530331, 562560, 562571, C07K 506, C07K 508, C07K 510, A61K 3702
Patent
active
053327268
ABSTRACT:
This invention relates to novel peptide and pseudopeptide derivatives and analogs of aspartic acid which are useful as inhibitors of platelet aggregation and thrombus formation in mammalian blood, to pharmaceutical compositions including such compounds, and to their use in inhibiting thrombus formation and platelet aggregation in mammals.
REFERENCES:
patent: 3821188 (1974-06-01), McKinley et al.
patent: 4629736 (1986-12-01), Tsukamoto et al.
patent: 4683291 (1987-07-01), Zimmerman et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4879313 (1989-11-01), Tjoeng et al.
patent: 4952562 (1990-08-01), Klein et al.
patent: 4992463 (1991-02-01), Tjoeng et al.
patent: 5023233 (1991-06-01), Nutt et al.
patent: 5037808 (1991-08-01), Tjoeng et al.
patent: 5053392 (1991-10-01), Klein et al.
patent: 5053393 (1991-10-01), Tjoeng et al.
patent: 5064814 (1991-11-01), Klein et al.
patent: 5086069 (1992-02-01), Klein et al.
patent: 5091396 (1992-02-01), Tjoeng et al.
patent: 5260277 (1993-11-01), McKenzie
Haverstick et al., Blood, vol. 66, No. 4, pp. 946-952, Oct. 1985, "Inhibition of Platelet Adhesion to Fibronectinb, Fibrinogen, and von Willebrand Factor Substrates".
Plow et al., Proc. Natl. Sci. USA, vol. 79, pp. 3711-3715, Jun. 1982, Biochemistry, "Inhibition of Fibrinogen Binding to Human Platelets by the Tetrapeptide Glycyl-L-prolyl-L-arginyl-L- . . . ".
Plow et al. Proc. Natl. Acad. Sci. USA, vol. 82, pp. 8057-8061, Dec. 1985, Cell Biol., "The Effect of Arg-Gly-Asp-containing Peptides on Fibrinogen and von Willebrand Factor Binding . . . ".
Fujimura et al., J. Biol. Chem., vol. 261, No. 1, pp. 381-385, Jan. 5, 1986, "von Willebrand Factor: A Reduced and Alkylated 52/48-kDa Fragment Beginning at Amino Acid . . . ".
Humphries et al., Science, vol. 233, pp. 467-470, Jul. 25, 1986, "A Synthetic Peptide from Fibronectin Inhibits Experimental Metastasis of Murine Melanoma Cells".
Cheresh et al., J. Biol. Chem, vol. 262, No. 36, Dec. 25, 1987, pp. 17703-17711, "Biosynthetic and Functional Properties of an Arg-Gly-Asp-directed Receptor Involved in Human . . . ".
Ginsberg et al., J. Biol. Chem., vol. 260, No. 7, pp. 3931-3936, Apr. 10, 1985, "Inhibition of Fibronectin Binding to Platelets by Proteolytic Fragments and Synthetic Peptides Which . . . ".
Ruggeri et al., Proc. Natl. Sci. USA, vol. 83, pp. 5708-5712, Aug. 1986, Med. Sci., "Inhibition of Platelet Function with Synthetic Peptides Designed to be High-Affinity Antagonists of Fibrinogen . . . ".
Gartner et al., J. Biol. Chem., vol. 260, No. 22, pp. 11891-11894, Oct. 5, 1985, "The Tetrapeptide Analogue of the Cell Attachment Site of Fibronectin Inhibits Platelet Aggregation and Fibrinogen . . . ".
Santoro et al., Cell, vol. 48, 867-873, Mar. 13, 1987, "Competition for Related but Nonidentical Binding Sites on the Glycoprotein IIb-IIIa Complex by Peptides Derived . . . ".
Parsons (ed.), Peptide Hormones, pp. 1-7, University Park Press, Baltimore, Md., (1976), "Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence".
Dayhoff, Atlas of Protein Sequence and Structure, vol. 5, pp. 89-99, (1972).
Becker Michael R.
Czekaj Mark
Dener Jeffrey M.
Gardner Charles
Klein Scott I.
Darkes Paul R.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Savitzky Martin F.
Walsh Stephen
Wax Robert A.
LandOfFree
Antithrombotic peptides and pseudopeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antithrombotic peptides and pseudopeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antithrombotic peptides and pseudopeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1053312